ZELLUNA IMMUNOTHERAPY AS
816823862ActivePioneering TCR-NK cell therapies to eliminate solid cancers safely.
Public Limited Liability Company (Biotechnology)zelluna.com
Yleiskatsaus
- 9
- Työntekijät
- 53t NOK
- Liikevaihto
- 2016
- Perustettu
Avainpäättäjät
Namir Hassan
Chief Executive Officer
@zelluna.com+44772XXXXXXX
Anders Tuv
Managing Director Radforsk Invest
@radforsk.no+47982XXXXX
Geir Christian Melen
Chief Financial Officer
@zelluna.com+47913XXXXX
Luise Weigand
Chief Scientific Officer
@zelluna.com
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Zelluna is a biotechnology company dedicated to eradicating solid cancers through innovative immune therapies. Its core mission involves unleashing the immune system's power using pioneering T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK. This novel platform is desi...
Ultimovacs AB